◼ Archived
Health
🔮 Newsylist predicts: still trending tomorrow low confidence — graded ✗ wrong
Cases of potentially deadly fungus detected in 23 states, CDC data shows. What to know
5sources
5articles
3velocity
+0%since first seen
2d agofirst detected
Who reported it (5)
- Drug-resistant ‘superbug’ fungus spreads to 23 states. What you should know KCCI · 2d ago
- Drug-resistant fungus on the rise in Tennessee: Here’s who’s most at risk WJHL · 2d ago
- Drug-resistant ‘superbug’ on the rise in Texas Dallas News · 2d ago
- Drug-resistant fungus Candida auris detected in 23 states so far this year KOMO · 2d ago
- Cases of potentially deadly fungus detected in 23 states, CDC data shows. What to know ABC News - Breaking News, Latest News and Videos · 2d ago broke it first
Momentum
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
Related trends
↓ Cooling
Health
🔮 holds
Everyone's talking about hormone therapy for menopause. Should I be on it?
Hormone replacement therapy use has nearly doubled since 2017 amid new guidelines and widespread public discussion.
↑ Rising
Health
🔮 fades
FDA approves 1st mRNA flu shot, from Moderna
The first mRNA-based influenza vaccine has received federal approval in the United States.
↑ Rising
Health
🔮 holds ✗
DNR Closes Additional Areas of Cunningham Falls State Park Following Second Beaver Attack
Two separate beaver attacks at Cunningham Falls State Park prompt additional closures in Maryland.
↓ Cooling
Health
🔮 fades
GLP-1 Drugs May Have a Hidden Effect on Your Eyes, Study Finds
New safety guidance and a lawsuit spotlight a possible eye‑risk link in popular GLP-1 weight‑loss drugs.
◼ Archived
Health
🔮 holds ✗
Pesticide exposure linked to higher risk of ALS, research finds
New research links occupational pesticide exposure to a significantly heightened risk of motor neuron diseases like ALS.
◼ Archived
Health
🔮 fades ✓
Breast cancer checks missing most women under 50 who are at risk, says study
Study finds NHS breast cancer guidelines miss 95% of high‑risk women under 50, sparking calls for review.